STAT5B and chronic myelogenous leukemia, BCR-ABL1 positive: These findings provide new insights into molecular and cellular mechanisms of a novel multikinase modulator in CML and suggest a potential therapeutic application of this compound in Bcr-Abl- and Stat5-related malignancies.